Response to Yang et al's "A Disproportionality Analysis on Benzoyl Peroxide and Its Risk of Malignancy Using the FDA Adverse Event Reporting System"

Authors

Jesse Veenstra, Henry Ford HealthFollow
David M. Ozog, Henry Ford HealthFollow
Sunita Ghosh, Henry Ford HealthFollow

Recommended Citation

Veenstra J, Ozog D, and Ghosh S. Response to Yang et al's "A Disproportionality Analysis on Benzoyl Peroxide and Its Risk of Malignancy Using the FDA Adverse Event Reporting System". J Invest Dermatol 2025.

Document Type

Article

Publication Date

7-4-2025

Publication Title

The Journal of investigative dermatology

Medical Subject Headings

Benzene; Benzoyl peroxide; Cancer; Epidemiology; Pharmacovigilance

PubMed ID

40613809

ePublication

ePub ahead of print